← All stocks

TriSalus Life Sciences, Inc.

TLSI No buying or selling
CIK 0001826667 #3504 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

18 insiders · 0 transactions
4.4×

Mary Szela holds only 4.4 times base salary in stock. $2.65M of shares against $600.92K in salary for 2025.

Salary from the company's own proxy. The shares are what Mary Szela last reported holding, valued at $2.46, the price Common Stock was last bought or sold at on the open market here, on 15 May 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Frankenius Equity AB
10% owner
6,989,748
$17.19M
+13.3%
Stansky Michael P
Director
1,640,420
$4.04M
+162.2%
MATLIN DAVID J
Director
1,323,210
$3.26M
+42.0%
Szela Mary T
CEO and President
1,077,683
$2.65M
+108.0%
HICKS KERRY R
Director
542,790
$1.34M
+5.5%
Murphy Sean
Director
321,721
$791.43K
+47.2%
Patience David
Chief Financial Officer
261,107
$642.32K
Desai Arjun JJ
Director
247,127
$607.93K
−10.8%
Cox Bryan F.
Chief of Research
163,415
$402.00K
+74.1%
Wahlstrom Mats
Director
147,555
$362.99K
Marshak Richard
Chief Commercial Officer
128,319
$315.66K
+329.0%
Stevens Jennifer
Chief Regulatory Officer
124,110
$305.31K
+278.6%
Devlin Jodi
Chief of Clinical Operations
97,364
$239.52K
+536.1%
Marshall Richard Henry
Chief Medical Officer
90,000
$221.40K
+200.0%
Valle William
Director
83,241
$204.77K
Young James Emmett
Chief Financial Officer
79,663
$195.97K
+763.5%
Gordon Gary B.
Director
72,510
$178.37K
Hyveled Liselotte
Director
10,040
$24.70K

No percentages here. This company's share count has moved by a factor of 2.0 over the window, from 30,493,137 to 61,574,600 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 28 Dec 2020